Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,652.7
-16.8 (-0.63%)

 

  • STI Straits Times Index
    2,652.7
    -16.8 (-0.63%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,591.8
    8.6 (0.54%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,727.4
    -482.8 (-1.84%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,383.3
    -67.3 (-1.95%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,290.8
    -238.5 (-1.06%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,031.3
    -21.5 (-0.43%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,451.9M
  • Value: 1,077.1M
  • Rise: 168
  • Fall: 215
  • Unch: 425

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
QT Vascular0.009+0.004
AsiaMedic0.031+0.011
Adventus0.025+0.005
Singapore-eDev0.130-0.003
Anchor Resources0.007+0.001
Medtecs Intl0.870+0.050
Clearbridge0.185+0.013
Biolidics0.410+0.100
3Cnergy0.019+0.002
Thomson Medical0.060+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CANCER GENETICS INC CANCER GENETICS
Updated on 10 Jul 2020 (End of trading day)
Last (USD): 3.040 Change: +0.140 High: 3.050 Remarks: -
Change (%): +4.83 Low: 2.820
Open 2.822 Yesterday's Close 2.9
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 40,171 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -6.66908 Trailing EPS (USD) e -5.14844 NAV (USD) b 2.8219
PE a - Trailing PE f - Price / NAV b 1.0773
Dividend (USD) d - Cash In Hand (USD) g 1.7440 Issued & Paid-up Shares c 2,260,880
Dividend Yield (%) d - Price / Cash In Hand g 1.743 Treasury Shares h -
Market Cap (M) 6.873 Enterprise Value (M) 4.564
Piotroski F Score 2 Exchange Code CGIX Par Value ( $ ) n.a.
52 Weeks Volatility (%) 135.32 Free Float (%) 89.2
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 15 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CANCER GENETICS INC NASDAQ 6.873 - - 1.0773 -
Industry Medical Specialties NASDAQ 2,383.835 415.077 112.392 8.2390 0.038
Local Peer INTUITIVE SURGICAL INC NASDAQ 67,156.808 48.689 48.443 7.8946 -
Local Peer DEXCOM INC NASDAQ 40,578.772 401.373 274.366 43.4230 -
Local Peer IDEXX LABORATORIES INC NASDAQ 28,728.587 67.167 65.761 266.8008 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 22,819.033 70.276 172.288 10.7784 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 21,525.113 48.614 11.395 7.5448 -
Local Peer HOLOGIC INC NASDAQ 14,897.195 - 24.176 7.1412 -
Local Peer INSULET CORPORATION NASDAQ 13,602.754 1,172.667 2,639.262 230.5525 -
Local Peer MASIMO CORPORATION NASDAQ 12,507.692 63.745 59.180 9.9800 -
Local Peer ABIOMED INC NASDAQ 11,914.615 58.690 58.690 11.1826 -
Local Peer QUIDEL CORP NASDAQ 10,358.633 142.052 117.293 17.1161 -
Local Peer DENTSPLY SIRONA INC NASDAQ 9,196.978 34.983 109.749 1.9620 0.902
Local Peer TANDEM DIABETES CARE INC NASDAQ 6,176.184 - - 29.8114 -
Other Local Peers BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ICU MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), INARI MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), CAREDX INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), ATRION CORP (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ZYNEX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), INMODE LTD (NASDAQ), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), INOGEN INC (NASDAQ), VERICEL CORP (NASDAQ), NATUS MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), QUOTIENT LTD (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), VIEWRAY INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), PROFOUND MED CORP (NASDAQ), IRADIMED CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), MISONIX INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), DERMTECH INC (NASDAQ), SOLITON INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), FONAR CORP (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), CELSION CORPORATION (NASDAQ), INTRICOM CORP (NASDAQ), BIOMERICA INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), NEPHROS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CONFORMIS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), IMMUCELL CORP (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), NEURONETICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), ELECTROCORE INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CHF SOLUTIONS INC (NASDAQ), BIOLASE INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), CHECK-CAP LTD (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AVINGER INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), DIGIRAD CORP (NASDAQ), DYNATRONICS CORP (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), ENDOLOGIX INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 164,573.804 44.892 46.503 5.4462 1.414
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 151,096.404 40.881 41.182 5.2907 0.201
Global Peer DANAHER CORP NYSE 130,120.460 52.282 47.541 4.4175 0.363
Global Peer MEDTRONIC PLC NYSE 121,803.453 25.434 25.434 2.4007 2.378
Global Peer BECTON DICKINSON & CO NYSE 72,958.990 67.430 80.175 3.4827 1.149
Global Peer STRYKER CORP NYSE 66,678.153 32.011 30.812 5.0841 1.199
Global Peer BOSTON SCIENTIFIC CORP NYSE 49,548.356 10.542 11.558 3.5894 -
Global Peer BAXTER INTERNATIONAL INC NYSE 43,368.092 43.325 42.476 5.6330 0.992
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 43,029.033 32.943 32.943 3.0431 1.907
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,025.612 40.143 37.936 10.7728 -
Other Global Peers ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), TOPGLOV (Bursa), HARTA (Bursa), FISHER & PAYKEL HEALTHCARE CORP (ASX), Top Glove (SGX), STERIS PLC (NYSE), WATERS CORP (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), QIAGEN NV (NYSE), MICROPORT (HKEx), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), KANGJI MEDICAL (HKEx), GLOBUS MED INC (NYSE), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), SUPERMX (Bursa), AK MEDICAL (HKEx), NEVRO CORP (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), PEIJIA-B (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), EBOS GROUP (ASX), CONMED CORP (NYSE), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), KDL MEDICAL (HKEx), LIFETECH SCI (HKEx), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), VAPOTHERM INC (NYSE), CIRC (HKEx), CRYOLIFE INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), CORMEDIX INC (NYSE American), YESTAR HEALTH (HKEx), MCP INCOME OPPORTUNITIES TRUST (ASX), PW MEDTECH (HKEx), Medtecs Intl (SGX), GOLDEN MEDITECH (HKEx), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), VINCENT MED (HKEx), UG Healthcare (SGX), ALPHA PRO TECH (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), INVACARE CORP (NYSE), MODERN DENTAL (HKEx), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), VOLITIONRX LIMITED (NYSE American), CYCLOPHARM LIMITED (ASX), Biolidics (SGX), EMVISION MEDICAL DEVICES LTD (ASX), RESAPP HEALTH LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), DAXOR CORP (NYSE American), SOMNOMED LIMITED (ASX), YUNNAN ENERGY (HKEx), NOVA EYE MEDICAL LIMITED (ASX), SDI LTD (ASX), LKL (Bursa), COMPUMEDICS (ASX), DIMERIX LTD (ASX), IMPEDIMED LIMITED (ASX), RESONANCE HEALTH LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), KELFRED (HKEx), RESPIRI LTD (ASX), ONCOCYTE CORP (NYSE American), INCANNEX HEALTHCARE LTD (ASX), MICRO-X LTD (ASX), Yunnan Energy (SGX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), OVENTUS MEDICAL LTD (ASX), USCOM LTD (ASX), METALICITY LIMITED (ASX), LBT INNOVATIONS LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), LIFE HEALTHCARE (HKEx), ALLEGRA ORTHOPAEDICS LIMITED (ASX), XTANT MEDICAL HLDGS INC (NYSE American), CARDIEX LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE), OPTISCAN IMAGING (ASX), Annica (SGX), ADHERIUM LIMITED (ASX), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), STHAI (SET), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.290
+10.55 %
10 Days --0.200
-6.17 %
20 Days --0.210
-6.46 %
Medium Term Return 3 Months --0.060
-1.94 %
6 Months --1.790
-37.06 %
1 Year --2.210
-42.10 %
Long Term Return 2 Years --23.252
-88.44 %
3 Years --110.960
-97.33 %
5 Years --360.560
-99.16 %
Annualised Return Annualised --
-61.59 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.920 - 9.500 Change From 1 Year Low +1.120 % Change From 1 Year Low (%) +58.33
Change From 1 Year High -6.460 % Change From 1 Year High (%) -68.00
2 Years Range 1.920 - 39.000 Change From 2 Years Low +1.120 % Change From 2 Years Low (%) +58.33
Change From 2 Years High -35.960 % Change From 2 Years High (%) -92.21
5 Years Range 1.920 - 367.440 Change From 5 Years Low +1.120 % Change From 5 Years Low (%) +58.33
Change From 5 Years High -364.400 % Change From 5 Years High (%) -99.17
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
10 Jul 2020 2.822 3.050 2.820 3.040 40,171 -
09 Jul 2020 2.980 2.980 2.790 2.900 12,404 -
08 Jul 2020 2.850 2.940 2.829 2.930 21,287 -
07 Jul 2020 3.010 3.010 2.835 2.870 27,282 -
06 Jul 2020 2.740 2.980 2.722 2.980 23,208 -
02 Jul 2020 2.850 2.880 2.700 2.750 36,278 -
01 Jul 2020 3.000 3.000 2.810 2.830 43,520 -
30 Jun 2020 3.140 3.140 2.910 3.030 24,627 -
29 Jun 2020 3.170 3.170 3.000 3.010 51,829 -
26 Jun 2020 3.160 3.240 2.990 3.240 50,414 -
25 Jun 2020 3.200 3.290 2.960 3.040 57,232 -
24 Jun 2020 3.290 3.410 3.170 3.170 44,327 -
23 Jun 2020 3.430 3.440 3.300 3.360 29,711 -
22 Jun 2020 3.490 3.590 3.380 3.410 30,373 -
19 Jun 2020 3.770 3.850 3.430 3.540 68,423 -
18 Jun 2020 3.460 3.690 3.460 3.550 39,436 -
17 Jun 2020 3.230 3.850 3.160 3.490 499,739 -
16 Jun 2020 3.340 3.360 3.200 3.217 76,145 -
15 Jun 2020 3.150 3.270 3.120 3.235 48,162 -
12 Jun 2020 3.300 3.400 3.170 3.250 109,119 -
11 Jun 2020 3.400 3.440 3.140 3.310 89,475 -
10 Jun 2020 3.800 3.850 3.500 3.500 88,655 -
Summary
Current 2 Weeks
(26 Jun 2020 to 10 Jul 2020)
3.160 3.240 2.700 3.040 331,020 -
Previous 2 Weeks
(12 Jun 2020 to 25 Jun 2020)
3.300 3.400 2.700 3.040 1,002,667 -
4 Weeks from
(14 May 2020 to 11 Jun 2020)
3.000 3.240 2.700 3.310 2,088,882 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.